Production scientifique des membres de l'équipe depuis 2005 (EA 6295 depuis 2012) :

Publications sur HAL (Archives ouvertes)

liste de publications (fichier PDF) liste interactive dans HAL
2018 PDF 2018 HAL
2017 PDF 2017 HAL
2016 PDF 2016 HAL
2015 PDF 2015 HAL
2011-2014 PDF 2011-2014 HAL

Publications 2014‑2015

Publications 2012‑2013

Publications 2005‑2011

Thèses 2003‑2018

Publications       2016

  • E. Allard-Vannier, K. Hervé-Aubert, K. Kaaki, T. Blondy, A. Shebanova, K.V. Shaitan, A.A. Ignatova, M.L. Saboungi, A.V. Feofanov, I. Chourpa

Folic acid-capped PEGylated magnetic nanoparticles enter cancer cells mostly via clathrin-dependent endocytosis.
BBA - General Subjects. 2016. doi: 10.1016/j.bbagen.2016.11.045

  • F. Bonnier, G. Brachet, R. Duong, T. Sojinrin, R. Respaud, N. Aubrey, M.J. Baker, H.J. Byrne, I. Chourpa

Screening the low molecular weight fraction of human serum using ATR-IR spectroscopy.
J Biophotonics. 2016, 9(10):1085-1097. doi: 10.1002/jbio.201600015

  • H.J. Byrne, P. Knief, M.E. Keating, F. Bonnier

Spectral pre and post processing for infrared and Raman spectroscopy of biological tissues and cells.
Chem Soc Rev. 2016, 45(7): 1865-1878. doi: 10.1039/c5cs00440c IF 34

  • H.T.P. Nguyen, E. Allard-Vannier, C. Gaillard, I. Eddaoudi, L. Miloudi, M. Soucé, I. Chourpa, E. Munnier

On the interaction of alginate-based core-shell nanocarriers with keratinocytes in vitro.
Colloids Surf B Biointerfaces. 2016, 142: 272-80. doi:10.1016/j.colsurfb.2016.02.055 IF 4,4

  • A. Gambade, S. Zreika, M. Guéguinou, I. Chourpa, G. Fromont-Hankard, A.M. Bouchet, J. Burlaud-Gaillard, M. Potier-Cartereau, S. Roger, V. Aucagne, S. Chevalier, C. Vandier, C. Goupille, G. Weber

Activation of TRPV2 and BKCa channels by the LL-37 enantiomers stimulates calcium entry and migration of cancer cells.
Oncotarget. 2016, doi: 10.18632/oncotarget.8122 IF 6,3

  • C. Alric, N. Aubrey, E. Allard-Vannier, A. di Tommaso, T. Blondy, I. Dimier-Poisson, I. Chourpa, K. Hervé-Aubert

Covalent conjugation of cysteine-engineered scFv to PEGylated magnetic nanoprobes for immunotargeting of breast cancer cells.
RSC Adv. 2016, 6, 37099-37109. doi: 10.1039/C6RA06076E IF 3,8

  • R. Respaud, D. Marchand, T. Pelat, K.-M. Tchou-Wong, C.J. Roy, C. Parent, M. Cabrera, J. Guillemain, R. Mac Loughlin, E. Levacher, A. Fontayne, L. Douziech-Eyrolles, A. Junqua-Moullet, L. Guilleminault, P. Thullier, E. Guillot-Combe, L. Vecellio, N. Heuzé-Vourc'h.

Development of a drug delivery system for efficient alveolar delivery of a neutralizing monoclonal antibody to treat pulmonary intoxication to ricin.
J Control Release. 2016, 234: 21-32. doi: 10.1016/j.jconrel.2016.05.018. IF 8.0

  • H.T. Nguyen, E. Munnier, X. Perse, F. Vial, F. Yvergnaux, T. Perrier, M. Soucé, I. Chourpa

Qualitative and Quantitative Study of the Potential of Lipid Nanocapsules of One Hundred Twenty Nanometers for the Topical Administration of Hydrophobic Molecules.
J Pharm Sci. 2016 Aug 9. pii: S0022-3549(16)41523-6. doi: 10.1016/j.xphs.2016.06.025. IF 2,6

  • Z. Farhane, F. Bonnier, M.A. Maher, J. Bryant, A. Casey, H.J. Byrne

Differentiating responses of lung cancer cell lines to Doxorubicin exposure: in vitro Raman micro spectroscopy, oxidative stress and bcl-2 protein expression.
J Biophotonics. 2016 Apr 18. doi: 10.1002/jbio.201600019. [Epub ahead of print] IF 3,8

  • A. Casey, M. Gargotti, F. Bonnier, H.J. Byrne

Chemotherapeutic efficiency of drugs in vitro: Comparison of doxorubicin exposure in 3D and 2D culture matrices.
Toxicol In Vitro. 2016, 33: 99-104. doi: 10.1016/j.tiv.2016.02.022. Epub 2016 Feb 27. IF 3,3